StreetInsider.com News Articles

SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference

Thu, 10 Sep 2026 08:35:00 -0400

DENVER, Sept. 10, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life announced today that Eric Schlorff, Chief Executive Officer of SeaStar Medical, will participate in the upcoming HC Wainwright 28th Annual Global Investment Conference being held September 14 to 16, 2026 in New York City.

The SeaStar Medical presentation will be available on September 11, 2026, at 7:00 am Eastern Time and can be accessed by visiting the Events &

SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference

Thu, 10 Sep 2026 08:35:00 -0400

The SeaStar Medical presentation will be available on September 11, 2026, at 7:00 am Eastern Time and can be accessed by visiting the Events &

Form 4 SeaStar Medical Holding For: Aug 18 Filed by: Messinger Michael

Wed, 19 Aug 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260819/26950348.html

Form 4 SeaStar Medical Holding For: Aug 18 Filed by: Messinger Michael

Wed, 19 Aug 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260819/26950348.html

SeaStar Medical (ICU) Misses Q1 EPS by 4c

Wed, 12 Aug 2026 17:14:56 -0400

SeaStar Medical (NASDAQ: ICU) reported Q1 EPS of ($0.91), $0.04 worse than the analyst estimate of ($0.87). Revenue for the quarter came in at $60 thousand versus the consensus estimate of $486.5 thousand.

For earnings history and earnings-related data on SeaStar Medical (ICU) click here.

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Wed, 12 Aug 2026 16:05:00 -0400

Added 3 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025

Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI

Obtained ICD-10-PCS codes to enable standardized inpatient hospital billing for its selective cytopheretic device (SCD) therapy, including QUELIMMUNE

Webcast today at 4:30 pm Eastern Time

DENVER, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its second quarter financial results after market close on Wednesday, August 12, 2026, and host a webcast and conference call to discuss its financial results and business progress.

Date/Time:

Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT

Webcast:

The live webcast and replay can be found

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

Date/Time:

Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT

Webcast:

The live webcast and replay can be found

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

Date/Time:

Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT

Webcast:

The live webcast and replay can be found

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

Date/Time:

Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT

Webcast:

The live webcast and replay can be found

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

Date/Time:

Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT

Webcast:

The live webcast and replay can be found

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

Date/Time:

Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT

Webcast:

The live webcast and replay can be found

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

Date/Time:

Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT

Webcast:

The live webcast and replay can be found

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Thu, 06 Aug 2026 08:35:00 -0400

Date/Time:	Wednesday, August 12, 2026, at 4:30 p.m. ET / 2:30 p.m. MT
Webcast:	The live webcast and replay can be found